NIDA Avenir Award
Supports early-stage investigators building addiction science in HIV, substance use, genetics, and epigenetic research.
The NIDA Avenir Award uses the DP2 mechanism to foster innovation from investigators at the very beginning of their independent research careers. NIDA describes Avenir recipients as "the future of addiction science." The award is available in two distinct tracks: Track 1 covers HIV and substance use, and Track 2 covers genetics and epigenetics of addiction. Each track has its own scientific scope …
Innovative addiction science by early-stage investigators across two tracks: HIV and substance use, or genetics and epigenetics of addiction.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
More from NIDA
All grants from this funder →One-Step, Rapid, Low-Cost Definitive Drug Testing at the Point of Need Challenge
🇺🇸NIDA · United States
Pays up to $600,000 in prizes to teams building rapid, low-cost drug-testing device prototypes.
NIDA SBIR/STTR
🇺🇸NIDA · United States
Supports United States. small businesses advancing drug abuse intervention and treatment technologies.
NIDA Avant-Garde Award
🇺🇸NIDA · United States
Offers support for innovative researchers pursuing high-impact HIV and substance use science across career stages.
2025 "$100,000 Start an SUD Startup" Challenge
🇺🇸NIDA · United States
Pays teams up to $10,000 each, plus six months of biotech mentoring, for drug-use research ideas.
Similar grants
Browse the directory →
NIMHD SBIR Phase IIB Strategic Breakthrough Award
🇺🇸NIMHD · United States
Funds prior NIH SBIR and STTR Phase II small businesses bridging later-stage R&D to commercialization.
AHA Career Development Award
AHA · United States
Supports career-stage cardiovascular investigators through structured development fellowships to strengthen real-world implementation.
NIDCD SBIR Phase I
🇺🇸NIDCD · United States
Supports United States. small businesses developing hearing, balance, and speech sensory technologies.
NIDCD SBIR Phase II
🇺🇸NIDCD · United States
Funds follow-up development for small businesses extending early sensory communication technologies into practical products.
NIMH SBIR/STTR
🇺🇸NIMH · United States
Supports United States. small businesses building mental health technologies through recurring NIH pathways.
NIA SBIR Phase I
🇺🇸NIA · United States
Supports small businesses developing aging and memory technologies at the feasibility stage.